SHIRE PHARMACEUTICALS LLC for SHIRE PHARMACEUTICALS LLC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 21, 2014 | $350,000 | Replaced |
| 1st Quarter - Amendment | Oct 29, 2014 | $360,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
orphan drug tax credt; issues surrounding ADHD, including economic and social impact; binge eating disorder; drug shortages;DEA processes; FDA funding and sequester; specialty tiers; track and trace; bundling rules for the Hospital Outpatient Prospective Payment System; compassionate use; step therapy; line extension rebates
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD BUCKLEY | — |
| JOHN EDWARD GREISSING New | Legal Fellow, Counsel, S. Committee on Judiciary |
| MARK LENKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.